Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Oppenheimer Downgrades Titan Medical to Perform

Oppenheimer analyst Suraj Kalia downgrades Titan Medical (NASDAQ:TMDI) from Outperform to Perform.

byBenzinga Newsdesk

March 25, 2022

1 minute read

Oppenheimer analyst Suraj Kalia downgrades Titan Medical (NASDAQ:TMDI) from Outperform to Perform.

JonesTrading Assumes Arcutis Biotherapeutics at Buy, Announces Price Target of $54

By Benzinga Newsdesk

Today, 7:56 AM

JonesTrading analyst Sean Kim assumes Arcutis Biotherapeutics (NASDAQ:ARQT) with a Buy rating and announces Price Target of $54.

ARQT

US Dept. Of Justice Says Kohl’s, Walmart Have Agreed To Pay $5.5M In Combined Penalties For Alleged Deceptive Violations Of Textile Act, Rules Related To Use Of Bamboo

By Benzinga Newsdesk

Today, 7:56 AM

-Reuters

KSS

News

GM North American Assembly Plant Scheduling Adjustments From Sept. 2 (List In Body)

By Benzinga Newsdesk

Today, 7:56 AM

GM North American Assembly Plant Scheduling Adjustments (September 2nd 2021) Fort Wayne Assembly (Indiana) and Silao Assembly (Mexico) to take downtime the week of 9/6. We currently anticipate regular

FDA
News

BiomX Announces Publication In The Journal, Bioinformatics

By Benzinga Newsdesk

Today, 7:56 AM

BiomX Announces Publication in the Journal, Bioinformatics Development of Exodus Algorithm Overcomes Limitations in Identifying and Quantifying the Genomes of Genetically Related Microorganisms BiomX Inc. (NYSE:PHGE)

PHGE

Oppenheimer Downgrades Titan Medical to Perform

Related Posts

JonesTrading Assumes Arcutis Biotherapeutics at Buy, Announces Price Target of $54

US Dept. Of Justice Says Kohl’s, Walmart Have Agreed To Pay $5.5M In Combined Penalties For Alleged Deceptive Violations Of Textile Act, Rules Related To Use Of Bamboo

GM North American Assembly Plant Scheduling Adjustments From Sept. 2 (List In Body)

BiomX Announces Publication In The Journal, Bioinformatics